Cargando…

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214598/
https://www.ncbi.nlm.nih.gov/pubmed/30464486
http://dx.doi.org/10.2147/TCRM.S192185
_version_ 1783368002740158464
collection PubMed
description
format Online
Article
Text
id pubmed-6214598
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62145982018-11-21 Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern] Ther Clin Risk Manag Expression of Concern Dove Medical Press 2018-10-30 /pmc/articles/PMC6214598/ /pubmed/30464486 http://dx.doi.org/10.2147/TCRM.S192185 Text en © 2018 Iwamoto et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Expression of Concern
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
title Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
title_full Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
title_fullStr Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
title_full_unstemmed Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
title_short Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
title_sort experience with alendronate treatment for four years among japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [expression of concern]
topic Expression of Concern
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214598/
https://www.ncbi.nlm.nih.gov/pubmed/30464486
http://dx.doi.org/10.2147/TCRM.S192185